Review of Curcumin Physicochemical Targeting Delivery System

References

• Di Maio M, Basch E, Bryce J, Perrone F. Patient-reported outcomes in the evaluation of toxicity of anticancer treatments. Nat Rev Clin Oncol. 2016;13(5):951–955. doi:10.1038/nrclinonc.2015.222
   Web of Science ®Google Scholar
• Cinci L, Mannelli LD, Maidecchi A, et al. Effects of Hypericum perforatum extract on oxaliplatin-induced neurotoxicity: in vitro evaluations. Z Naturforsch C. 2017;72(5–6):219–226. doi:10.1515/znc-2016-019428160544
   PubMed Web of Science ®Google Scholar
• Malekinejad H, Ahsan S, Delkhoshkasmaie F, et al. Cardioprotective effect of royal jelly on paclitaxel-induced cardio-toxicity in rats. Iran J Basic Med Sci. 2016;19(2):221–227.27081469
   PubMed Web of Science ®Google Scholar
• Mullally WJ, O’Súilleabháin CB, Brady C, et al. Vinorelbine induced perforation of a metastatic gastric lesion. Irish J Med Sci. 2017;186(3):571–575. doi:10.1007/s11845-016-1536-128039597
   PubMed Web of Science ®Google Scholar
• Ninan PJ, Prasath D, James M. Toxicity and tolerability of paclitaxel and carboplatin regime in patients with epithelial ovarian cancer at a tertiary care hospital. SSRG Int J Med Sci. 2018;5(1):2393–9117.
   Google Scholar
• Zhao SJ, Pi C, Ye Y, Zhao L, Wei YM. Recent advances of analogues of curcumin for treatment of cancer. Eur J Med Chem. 2019;180:524–535. doi:10.1016/j.ejmech.2019.07.03431336310
   PubMed Web of Science ®Google Scholar
• Gupta SC, Patchva S, Aggarwal BB. Therapeutic roles of Curcumin: lessons learned from clinical trials. AAPS J. 2013;15(1):195–218. doi:10.1208/s12248-012-9432-823143785
   PubMed Web of Science ®Google Scholar
• Moghadamtousi SZ, Kadir HA, Hassandarvish P, et al. A review on antibacterial, antiviral, and antifungal activity of curcumin. Biomed Res Int. 2014;2014(1):186864.24877064
   PubMedGoogle Scholar
• Marchiani A, Rozzo C, Fadda A, et al. Curcumin and curcumin-like molecules: from spice to drugs. Curr Med Chem. 2014;21(2):204–222. doi:10.2174/09298673210213120611581023590716
   PubMed Web of Science ®Google Scholar
• Shen L, Liu L, Ji HF. Regulative effects of curcumin spice administration on gut microbiota and its pharmacological implications. Food Nutr Res. 2017;61(1):1361780. doi:10.1080/16546628.2017.136178028814952
   PubMed Web of Science ®Google Scholar
• Feng T, Wei Y, Lee RJ, et al. Liposomal curcumin and its application in cancer. Int J Nanomed. 2017;12:6027–6044. doi:10.2147/IJN.S132434
   PubMed Web of Science ®Google Scholar
• Ramasamy TS, Ayob AZ, Myint HHL, et al. Targeting colorectal cancer stem cells using curcumin and curcumin analogues: insights into the mechanism of the therapeutic efficacy. Cancer Cell Int. 2015;15(1):96. doi:10.1186/s12935-015-0241-x26457069
   PubMedGoogle Scholar
• Vishvakarma NK. Novel antitumor mechanisms of curcumin: implication of altered tumor metabolism, reconstituted tumor microenvironment and augmented myelopoiesis. Phytochem Rev. 2014;13(3):717–724. doi:10.1007/s11101-014-9364-2
   Web of Science ®Google Scholar
• Prasad S, Tyagi AK, Aggarwal BB. Recent developments in delivery, bioavailability, absorption and metabolism of curcumin: the golden pigment from golden spice. Cancer Res Treat. 2014;46(1):2–18. doi:10.4143/crt.2014.46.1.224520218
   PubMed Web of Science ®Google Scholar
• Yallapu MM, Nagesh PKB, Jaggi M, Chauhan SC. Therapeutic applications of curcumin nanoformulations. AAPS J. 2015;17(6):1341–1356. doi:10.1208/s12248-015-9811-z26335307
   PubMed Web of Science ®Google Scholar
• Maeda H, Nakamura H, Fang J. The EPR effect for macromolecular drug delivery to solid tumors: improvement of tumor uptake, lowering of systemic toxicity, and distinct tumor imaging in vivo. Adv Drug Deliv Rev. 2013;65(1):71–79. doi:10.1016/j.addr.2012.10.00223088862
   PubMed Web of Science ®Google Scholar
• Bertrand N, Wu J, Xu XY, Kamaly N, Farokhzad OC. Cancer nanotechnology: the impact of passive and active targeting in the era of modern cancer biology. Adv Drug Deliv Rev. 2014;66(1):2–25. doi:10.1016/j.addr.2013.11.00924270007
   PubMedGoogle Scholar
• Gera M, Sharma N, Ghosh M, et al. Nanoformulations of curcumin: an emerging paradigm for improved remedial application. Oncotarget. 2017;8(39):66680–66698. doi:10.18632/oncotarget.1916429029547
   PubMedGoogle Scholar
• Naksuriya O, Okonogi S, Schiffelers RM, et al. Curcumin nanoformulations: a review of pharmaceutical properties and preclinical studies and clinical data related to cancer treatment. Biomaterials. 2014;35(10):3365–3383. doi:10.1016/j.biomaterials.2013.12.09024439402
   PubMed Web of Science ®Google Scholar
• Tajbakhsh A, Hasanzadeh M, Rezaee M, et al. Therapeutic potential of novel formulated forms of curcumin in the treatment of breast cancer by the targeting of cellular and physiological dysregulated pathways. J Cell Physiol. 2017;233:3.
   Web of Science ®Google Scholar
• Wei D, Hui L. Research progress in new formulation of curcumin for anti-tumor. Acad J Second Military Med Univ. 2015;36(7):771–775.
   Google Scholar
• Lee WH, Loo CY, Young PM, et al. Recent advances in curcumin nanoformulation for cancer therapy. Expert Opin Drug Deliv. 2014;11(8):1183–1201. doi:10.1517/17425247.2014.91668624857605
   PubMed Web of Science ®Google Scholar
• Dagar P, Dahiya P, Bhambi M. Recent advances in curcumin nanoformulations. Nano Sci Nano Technol an Indian J. 2014;8(12):458–474.
   Google Scholar
• Hashemi M, Ebrahimian M. Recent advances in nanoformulations for co-delivery of curcumin and chemotherapeutic drugs. Int J Nanomed. 2017;4(1):1–7.
   Google Scholar
• Wang M, Thanou M. Targeting nanoparticles to cancer. Pharmacol Res. 2010;62(2):90–99. doi:10.1016/j.phrs.2010.03.00520380880
   PubMed Web of Science ®Google Scholar
• Wang JJ, Huang SW. Research progress on novel carrier-modified methods and evaluation of active targeting antitumor preparation. Chin Herb Med. 2014;6(1):22–28. doi:10.1016/S1674-6384(14)60002-2
   Google Scholar
• Sonekar S, Mishra M, Patel A, et al. Formulation and evaluation of folic acid conjugated gliadin nanoparticles of curcumin for targeting colon cancer cells. J Appl Pharm Sci. 2016;6(10):068–074. doi:10.7324/JAPS.2016.601009
   Google Scholar
• Wen X, Cheng X, Hu D, et al. Combination of curcumin with an anti-transferrin receptor antibody suppressed the growth of malignant gliomas in vitro. Turk Neurosurg. 2016;26(2):209–214.26956814
   PubMed Web of Science ®Google Scholar
• Mulik RS, Mönkkönen J, Juvonen RO, et al. Transferrin mediated solid lipid nanoparticles containing curcumin: enhanced in vitro anticancer activity by induction of apoptosis. Int J Pharm. 2010;398(1):190–203. doi:10.1016/j.ijpharm.2010.07.02120655375
   PubMedGoogle Scholar
• Felber AE, Dufresne MH, Leroux JC. pH-sensitive vesicles, polymeric micelles, and nanospheres prepared with polycarboxylates. Adv Drug Deliv Rev. 2012;64(11):979–992. doi:10.1016/j.addr.2011.09.00621996056
   PubMed Web of Science ®Google Scholar
• Tila D, Yazdaniarazi SN, Ghanbarzadeh S, et al. pH-sensitive, polymer modified, plasma stable niosomes: promising carriers for anti-cancer drugs. Excli Journal. 2015;14(4):21.26417350
   PubMedGoogle Scholar
• Hu FQ, Zhang YY, You J, et al. pH triggered doxorubicin delivery of PEGylated glycolipid conjugate micelles for tumor targeting therapy. Mol Pharm. 2012;9(9):2469–2478. doi:10.1021/mp300002v22827551
   PubMedGoogle Scholar
• Wu T, Hua MY, Chen JP, et al. Effects of external magnetic field on biodistribution of nanoparticles: A histological study. J Magn Magn Mater. 2007;311(1):372–375. doi:10.1016/j.jmmm.2006.10.1202
   Web of Science ®Google Scholar
• Yallapu MM, Ebeling MC, Khan S, et al. Novel curcumin-loaded magnetic nanoparticles for pancreatic cancer treatment. Mol Cancer Ther. 2013;12(8):1471–1480. doi:10.1158/1535-7163.MCT-12-122723704793
   PubMed Web of Science ®Google Scholar
• Cui Y, Zhang M, Zeng F, Jin HY, Xu Q, Huang YZ. Dual-targeting magnetic PLGA nanoparticles for codelivery of paclitaxel and curcumin for brain tumor therapy. Acs Appl Mater Inter. 2016;8(47):32159–32169. doi:10.1021/acsami.6b10175
   PubMed Web of Science ®Google Scholar
• Li ZQ, Guan JJ. Thermosensitive hydrogels for drug delivery. Expert Opin Drug Deliv. 2011;8(8):991–1007. doi:10.1517/17425247.2011.58165621564003
   PubMed Web of Science ®Google Scholar
• Vaupel P. Tumor microenvironmental physiology and its implications for radiation oncology. Semin Radiat Oncol. 2004;14(3):198–206. doi:10.1016/j.semradonc.2004.04.00815254862
   PubMed Web of Science ®Google Scholar
• Bueno PVA, Souza PR, Follmann HDM, et al. N,N-Dimethyl chitosan/heparin polyelectrolyte complex vehicle for efficient heparin delivery. Int J Biol Macromol. 2015;75:186–191. doi:10.1016/j.ijbiomac.2015.01.03025625782
   PubMed Web of Science ®Google Scholar
• Talaie F, Atyabi F, Azjdarzadeh M, et al. Overcoming therapeutic obstacles in inflammatory bowel diseases: A comprehensive review on novel drug delivery strategies. Eur J Pharm Sci. 2013;49(4):712–722. doi:10.1016/j.ejps.2013.04.03123665411
   PubMed Web of Science ®Google Scholar
• Ju L, Cailin F, Wenlan W, et al. Preparation and properties evaluation of a novel pH-sensitive liposomes based on imidazole-modified cholesterol derivatives. Int J Pharm. 2016;518(1–2):213–219. doi:10.1016/j.ijpharm.2016.11.04427889588
   PubMedGoogle Scholar
• Moku G, Gulla SK, Nimmu NV, et al. Delivering anti-cancer drugs with endosomal pH-sensitive anti-cancer liposomes. Biomater Sci. 2016;4(4):627–638. doi:10.1039/C5BM00479A26806172
   PubMed Web of Science ®Google Scholar
• Jelezova I, Drakalska E, Momekova D, et al. Curcumin loaded pH-sensitive hybrid lipid/block copolymer nanosized drug delivery systems. Eur J Pharm Sci. 2015;78:67–78. doi:10.1016/j.ejps.2015.07.00526159739
   PubMed Web of Science ®Google Scholar
• De LV, Milano F, Mancini E, et al. Encapsulation of curcumin-loaded liposomes for colonic drug delivery in a pH-responsive polymer cluster using a pH-driven and organic solvent-free process. Molecules. 2018;23(4):739. doi:10.3390/molecules23040739
   PubMed Web of Science ®Google Scholar
• Gugulothu D, Kulkarni A, Patravale V, et al. pH-sensitive nanoparticles of curcumin–celecoxib combination: evaluating drug synergy in ulcerative colitis model. J Pharm Sci. 2014;103(2):687–696. doi:10.1002/jps.2382824375287
   PubMed Web of Science ®Google Scholar
• Dandekar P, Dhumal R, Jain R, et al. Toxicological evaluation of pH-sensitive nanoparticles of curcumin: acute, sub-acute and genotoxicity studies. Food Chem Toxicol. 2010;48(8):2073–2089. doi:10.1016/j.fct.2010.05.00820470854
   PubMed Web of Science ®Google Scholar
• Wahlstrom B, Blennow G. A study on the fate of curcumin in the rat. Acta Pharmacol Toxicol. 1978;43(2):86–92. doi:10.1111/j.1600-0773.1978.tb02240.x
   PubMedGoogle Scholar
• Beloqui A, Coco R, Memvanga PB, et al. pH-sensitive nanoparticles for colonic delivery of curcumin in inflammatory bowel disease. Int J Pharm. 2014;473(1–2):203–212.25014369
   PubMed Web of Science ®Google Scholar
• Prajakta D, Ratnesh J, Chandan K, et al. Curcumin loaded pH-sensitive nanoparticles for the treatment of colon cancer. J Biomed Nanotechnol. 2009;5(5):445–455. doi:10.1166/jbn.2009.103820201417
   PubMed Web of Science ®Google Scholar
• Huang YC, Lam UI. Chitosan/fucoidan pH sensitive nanoparticles for oral delivery system. J Chin Chem Soc. 2011;58(6):779–785. doi:10.1002/jccs.201190121
   Web of Science ®Google Scholar
• Abouaitah KE, Farghali AA, Swiderska-Sroda A, et al. pH-controlled release system for curcumin based on functionalized dendritic mesoporous silica nanoparticles. J Nanomed Nanotechnol. 2016;7(1):351.
   Google Scholar
• Kim S, Philippot S, Fontanay S, et al. pH- and glutathione-responsive release of curcumin from mesoporous silica nanoparticles coated using tannic acid-Fe(III) complex. RSC Adv. 2015;5(110):90550–90558. doi:10.1039/C5RA16004A
   Web of Science ®Google Scholar
• Daryasari MP, Akhgar MR, Mamashli F, et al. Chitosan-folate coated mesoporous silica nanoparticles as a smart and pH-sensitive system for curcumin delivery. RSC Adv. 2016;6(107):105578–105588. doi:10.1039/C6RA23182A
   Web of Science ®Google Scholar
• Gao Y, Li Y, Li Y, et al. PSMA-mediated endosome escape-accelerating polymeric micelles for targeted therapy of prostate cancer and the real time tracing of their intracellular trafficking. Nanoscale. 2014;7(2):597–612. doi:10.1039/C4NR05738D
   Web of Science ®Google Scholar
• Zhang J, Li J, Shi Z, et al. pH-sensitive polymeric nanoparticles for co-delivery of doxorubicin and curcumin to treat cancer via enhanced pro-apoptotic and anti-angiogenic activities. Acta Biomater. 2017;58:349–364. doi:10.1016/j.actbio.2017.04.02928455219
   PubMed Web of Science ®Google Scholar
• Zhang Y, Yang C, Wang W, et al. Co-delivery of doxorubicin and curcumin by pH-sensitive prodrug nanoparticle for combination therapy of cancer. Sci Rep. 2016;6(1):21225. doi:10.1038/srep2122526876480
   PubMedGoogle Scholar
• Lu W, Wan J, She ZJ, Jiang XG. Brain delivery property and accelerated blood clearance of cationic albumin conjugated pegylated nanoparticle. J Control Release. 2007;118(1):38–53. doi:10.1016/j.jconrel.2006.11.01517240471
   PubMed Web of Science ®Google Scholar
• Ishihara T, Takeda M, Sakamoto H, et al. Accelerated blood clearance phenomenon upon repeated injection of PEG-modified PLA-nanoparticles. Pharm Res. 2009;26(10):2270–2279. doi:10.1007/s11095-009-9943-x19633820
   PubMed Web of Science ®Google Scholar
• Gao C, Tang F, Gong G, et al. pH-Responsive prodrug nanoparticles based on a sodium alginate derivative for selective co-release of doxorubicin and curcumin into tumor cells. Nanoscale. 2017;9(34):12533. doi:10.1039/C7NR03611F28819666
   PubMed Web of Science ®Google Scholar
• Xing ZH, Wei JH, Cheang TY, et al. Bifunctional pH-sensitive Zn(II)-curcumin nanoparticles/siRNA effectively inhibit growth of human bladder cancer cells. J Mater Chem B. 2014;2(18):2714–2724. doi:10.1039/c3tb21625j32261437
   PubMed Web of Science ®Google Scholar
• Wang DS, Zhou YX, Li CW, et al. Recent progress in research of pH-sensitive polymeric micelles as drug delivery system. Chin J New Drugs. 2016;25(19):2218–2224.
   Google Scholar
• Sajomsang W, Gonil P, Saesoo S, et al. Synthesis and anticervical cancer activity of novel pH responsive micelles for oral curcumin delivery. Int J Pharm. 2014;477(1–2):261–272. doi:10.1016/j.ijpharm.2014.10.04225455774
   PubMedGoogle Scholar
• Zhai S, Ma Y, Chen Y, et al. Synthesis of an amphiphilic block copolymer containing zwitterionic sulfobetaine as a novel pH-sensitive drug carrier. Polym Chem. 2014;5(4):1285–1297.
   Web of Science ®Google Scholar
• Wu Z, Cai M, Xie X, et al. The effect of architecture/composition on the pH sensitive micelle properties and in vivo study of curcuminin-loaded micelles containing sulfobetaines. RSC Adv. 2015;5(129):106989–107000. doi:10.1039/C5RA20847E
   Web of Science ®Google Scholar
• Wei H, Shi H, Qiao M, et al. pH-sensitive micelles for the intracellular co-delivery of curcumin and Pluronic L61 unimers for synergistic reversal effect of multidrug resistance. Sci Rep. 2017;7:42465. doi:10.1038/srep4246528195164
   PubMed Web of Science ®Google Scholar
• Plasschaert SLA, de Bont ESJM, Boezen M, et al. Expression of multidrug resistance-associated proteins predicts prognosis in childhood and adult acute lymphoblastic leukemia. Clin Cancer Res. 2005;11(24 Pt 1):8661–8668. doi:10.1158/1078-0432.CCR-05-109616361551
   PubMed Web of Science ®Google Scholar
• Szakacs G, Paterson JK, Ludwig JA, Booth-Genthe C, Gottesman MM. Targeting multidrug resistance in cancer. Nat Rev Drug Discov. 2006;5(3):219–234.16518375
   PubMed Web of Science ®Google Scholar
• Alvarez AI, Real R, Pérez MG, Prieto JG, Merino G. Modulation of the activity of ABC transporters (P-glycoprotein, MRP2, BCRP) by flavonoids and drug response. J Pharm Sci. 2010;99(2):598–617. doi:10.1002/jps.2185119544374
   PubMed Web of Science ®Google Scholar
• Evers R, Kool M, Smith AJ, van Deemter L, de Haas M, Borst P. Inhibitory effect of the reversal agents V-104, GF120918 and Pluronic L61 on MDR1 Pgp-, MRP1- and MRP2-mediated transport. Br J Cancer. 2000;83(3):366–374. doi:10.1054/bjoc.2000.126010917553
   PubMed Web of Science ®Google Scholar
• Raveendran R, Bhuvaneshwar GS, Sharma CP. Hemocompatible curcumin-dextran micelles as pH sensitive pro-drugs for enhanced therapeutic efficacy in cancer cells. Carbohyd Polym. 2016;137:497–507. doi:10.1016/j.carbpol.2015.11.017
   PubMed Web of Science ®Google Scholar
• Fang XB, Zhang JM, Xie X, et al. pH-sensitive micelles based on acid-labile pluronic F68-curcumin conjugates for improved tumor intracellular drug delivery. Int J Pharm. 2016;502(1–2):28–37. doi:10.1016/j.ijpharm.2016.01.02926784981
   PubMed Web of Science ®Google Scholar
• Li H, Li M, Chen C, et al. On-demand combinational delivery of curcumin and doxorubicin via a pH-labile micellar nanocarrier. Int J Pharm. 2015;495(1):572–578. doi:10.1016/j.ijpharm.2015.09.02226387617
   PubMedGoogle Scholar
• Yang RL, Zhang SA, Kong DL, et al. Biodegradable polymer-curcumin conjugate micelles enhance the loading and delivery of low-potency curcumin. Pharm Res. 2012;29(12):3512–3525. doi:10.1007/s11095-012-0848-822961588
   PubMed Web of Science ®Google Scholar
• Yu H, Mu H, Xiu L, et al. A novel ketal-based chitosan as nano-vehicles for potential pH-sensitive nanomedicine delivery. Nanosci Nanotech Let. 2013;5(9):1007–1011. doi:10.1166/nnl.2013.1660
   Web of Science ®Google Scholar
• Sareen R, Jain N, Rajkumari A, et al. pH triggered delivery of curcumin from Eudragit-coated chitosan microspheres for inflammatory bowel disease: characterization and pharmacodynamic evaluation. Drug Deliv. 2016;23(1):55–62.
   Web of Science ®Google Scholar
• Kumar S, KesharwaniHimanshi Mathur SS, Tyagi M, et al. Molecular complexation of curcumin with pH sensitive cationic copolymer enhances the aqueous solubility, stability and bioavailability of curcumin. Eur J Pharm Sci. 2016;82:86–96. doi:10.1016/j.ejps.2015.11.01026588875
   PubMed Web of Science ®Google Scholar
• Patra D, Sleem F. A new method for pH triggered curcumin release by applying poly(L-lysine) mediated nanoparticle-congregation. Anal Chim Acta. 2013;795(18):60–68. doi:10.1016/j.aca.2013.07.06323998538
   PubMedGoogle Scholar
• Lin YP, Zhang K, Zhang RH, et al. Magnetic nanoparticles applied in targeted therapy and magnetic resonance imaging: crucial preparation parameters, indispensable pre-treatments, updated research advancements and future perspectives. J Mater Chem B. 2020;8(28):5973–5991. doi:10.1039/D0TB00552E32597454
   PubMed Web of Science ®Google Scholar
• Asnaashari Eivari H, Rahdar A, Arabi H. Preparation of super paramagnetic iron oxide nanoparticles and investigation their magnetic properties. Int J Eng Sci Invest. 2012;1(3):2251–8843.
   Google Scholar
• Gao YL, Zhu GM, Ma TT. Progress in Fe3O4 magnetic nanoparticles and its application in biomedical fields. Chem Ind Eng Prog. 2017;36(3):973–980.
   Google Scholar
• Pankhurst QA, Connolly JS, Jones SK, Dobso J. Application of magnetic nanoparticles in biomedicine. J Phys D Appl Phys. 2003;36(13):R167–R181. doi:10.1088/0022-3727/36/13/201
   Web of Science ®Google Scholar
• Janjic JM, Shao P, Zhang S, et al. Perfluorocarbon nanoemulsions with fluorescent, colloidal and magnetic properties. Biomaterials. 2014;35(18):4958–4968. doi:10.1016/j.biomaterials.2014.03.00624674463
   PubMed Web of Science ®Google Scholar
• Yan H, Zhang JC, You CX, Song ZW, Yu BW, Shen Y. Surface modification of Fe3O4 nanoparticles and their magnetic properties. Int J Min Met Mater. 2009;16(002):226–229. doi:10.1016/S1674-4799(09)60038-8
   Google Scholar
• Jain TK, Richey J, Strand M, Leslie-Pelecky DL, Flask CA, Labhasetwar V. Magnetic nanoparticles with dual functional properties: drug delivery and magnetic resonance imaging. Biomaterials. 2008;29(29):4012–4021. doi:10.1016/j.biomaterials.2008.07.00418649936
   PubMed Web of Science ®Google Scholar
• Pilapong C, Sitthichai S, Thongtem S, Thongtem T. Smart magnetic nanoparticle-aptamer probe for targeted imaging and treatment of hepatocellular carcinoma. Int J Pharm. 2014;473(1–2):469–474. doi:10.1016/j.ijpharm.2014.07.03625089503
   PubMedGoogle Scholar
• Kasai H, Kawai K, Shiraishi T, et al. Effects of Fe3O4 Magnetic Nanoparticles on A549 Cells. Int J Mol Sci. 2013;14(8):15546–15560. doi:10.3390/ijms14081554623892599
   PubMed Web of Science ®Google Scholar
• Polo E, Pino PD, Pardo A, et al. Magnetic nanoparticles for cancer therapy and bioimaging. Nanooncology. 2018;239–279.
   Google Scholar
• Sideris S, Aoun F, Zanaty M, et al. Efficacy of weekly paclitaxel treatment as a single agent chemotherapy following first-line cisplatin treatment in urothelial bladder cancer. Mol Clin Oncol. 2016;4(6):1063–1067. doi:10.3892/mco.2016.82127284445
   PubMedGoogle Scholar
• Bae YJ, Yoon YI, Yoon TJ, et al. Ultrasound-guided delivery of siRNA and a chemotherapeutic drug by using microbubble complexes: in vitro and in vivo evaluations in a prostate cancer model. Korean J Radiol. 2016;17(4):497–508.27390541
   PubMed Web of Science ®Google Scholar
• Meador CB, Jin H, De SE, et al. Optimizing the sequence of anti-EGFR targeted therapy in EGFR-mutant lung cancer. Mol Cancer Ther. 2015;14(2):542–552. doi:10.1158/1535-7163.MCT-14-072325477325
   PubMed Web of Science ®Google Scholar
• Yonesaka K, Hirotani K, Kawakami H, et al. Anti-HER3 monoclonal antibody patritumab sensitizes refractory non-small cell lung cancer to the epidermal growth factor receptor inhibitor erlotinib. Oncogene. 2015;35(7):878–886. doi:10.1038/onc.2015.14225961915
   PubMed Web of Science ®Google Scholar
• Zhou Q, Ye M, Lu Y, et al. Curcumin improves the tumoricidal effect of mitomycin C by suppressing ABCG2 expression in stem cell-like breast cancer cells. PLoS One. 2015;10(8):e0136694. doi:10.1371/journal.pone.013669426305906
   PubMed Web of Science ®Google Scholar
• Talekar M, Ouyang Q, Goldberg MS, et al. Cosilencing of PKM-2 and MDR-1 sensitizes multidrug-resistant ovarian cancer cells to paclitaxel in a murine model of ovarian cancer. Mol Cancer Ther. 2015;14(7):1521–1531. doi:10.1158/1535-7163.MCT-15-010025964202
   PubMed Web of Science ®Google Scholar
• Mancarella S, Greco V, Baldassarre F, et al. Polymer-coated magnetic nanoparticles for curcumin delivery to cancer cells. Macromol Biosci. 2015;15(10):1365–1374. doi:10.1002/mabi.20150014226085082
   PubMed Web of Science ®Google Scholar
• Chin SF, Iyer KS, Saunders M, et al. Encapsulation and sustained release of curcumin using superparamagnetic silica reservoirs. Chem-Eur J. 2010;15(23):5661–5665. doi:10.1002/chem.200802747
   Web of Science ®Google Scholar
• Silambarasi T, Latha S. Formulation and evaluation of curcumin loaded magnetic nanoparticles for cancer therapy. Int J Pharm Sci & Res. 2012;3(5):1–16.
   Google Scholar
• Latorre M, Rinaldi C. Applications of magnetic nanoparticles in medicine: magnetic fluid hyperthermia. P R Health Sci J. 2009;28(3):227–238.19715115
   PubMed Web of Science ®Google Scholar
• Cheng KK, Wang YX, Chow AHL, et al. Amyloid plaques binding curcumin conjugated magnetic nanoparticles for diagnosis in Alzheimer’s disease TG2576 mice. Alzheimers Dement. 2014;10(4):152–153. doi:10.1016/j.jalz.2014.04.12223954029
   PubMedGoogle Scholar
• Cheng KK, Chan PS, Fan S, et al. Curcumin-conjugated magnetic nanoparticles for detecting amyloid plaques in Alzheimer’s disease mice using magnetic resonance imaging (MRI). Biomaterials. 2015;44(44):155–172. doi:10.1016/j.biomaterials.2014.12.00525617135
   PubMedGoogle Scholar
• Magro M, Campos R, Baratella D, et al. A magnetically drivable nanovehicle for curcumin with antioxidant capacity and MRI relaxation properties. Chemistry. 2015;20(37):11913–11920. doi:10.1002/chem.201402820
   Web of Science ®Google Scholar
• Yallapu MM, Othman SF, Curtis ET, et al. Curcumin-loaded magnetic nanoparticles for breast cancer therapeutics and imaging applications. Int J Nanomed. 2012;7(1):1761–1779.
   PubMedGoogle Scholar
• Salem M. Curcumin-loaded magnetic nanoaggregates conjugated with folic acid for targeted cancer treatment. Electronic Thesis Dissertation Repository. 2014;2206.
   Google Scholar
• Manju S, Sharma CP, Sreenivasan K. Targeted coadministration of sparingly soluble paclitaxel and curcumin into cancer cells by surface engineered magnetic nanoparticles. J Mater Chem. 2011;21(39):15708–15717. doi:10.1039/c1jm12528a
   Web of Science ®Google Scholar
• Akrami M, Khoobi M, Khalilvand-Sedagheh M, et al. Evaluation of multilayer coated magnetic nanoparticles as biocompatible curcumin delivery platforms for breast cancer treatment. RSC Adv. 2015;5(107):88096–88107. doi:10.1039/C5RA13838H
   Web of Science ®Google Scholar
• Zhou Y, Wang C, Wang F, et al. β-Cyclodextrin and its derivatives functionalized magnetic nanoparticles for targeting delivery of curcumin and cell imaging. Chin J Chem. 2016;34(6):599–608. doi:10.1002/cjoc.201500756
   Web of Science ®Google Scholar
• Almeida EAMS, Bellettini IC, Garcia FP, et al. Curcumin-loaded dual pH- and thermo-responsive magnetic microcarriers based on pectin maleate for drug delivery. Carbohyd Polym. 2017;171:259–266. doi:10.1016/j.carbpol.2017.05.034
   PubMed Web of Science ®Google Scholar
• Tang YD, Jin T, Flesch RCC. Numerical temperature analysis of magnetic hyperthermia considering nanoparticle clustering and blood vessels. IEEE T Magn. 2017;53(10):1–6. doi:10.1109/TMAG.2017.2722425
   Web of Science ®Google Scholar
• Hardiansyah A, Yang MC, Liu TY, et al. Hydrophobic drug-loaded PEGylated magnetic liposomes for drug-controlled release. Nanoscale Res Lett. 2017;12(1):355. doi:10.1186/s11671-017-2119-428525950
   PubMedGoogle Scholar
• Hu L, Huang M, Wang J, et al. Preparation of magnetic poly(lactic-co-glycolic acid) microspheres with a controllable particle size based on a composite emulsion and their release properties for curcumin loading. J Appl Polym Sci. 2016;133(16):43317. doi:10.1002/app.43317
   Web of Science ®Google Scholar
• Kini S, Bahadur D, Panda D. Magnetic PLGA nanospheres: a dual therapy for cancer. Ieee T Magn. 2011;47(10):2882–2886. doi:10.1109/TMAG.2011.2158403
   Web of Science ®Google Scholar
• Hu RL, Ke XF, Jiang H, et al. Effect of interleukin-2 treatment combined with magnetic fluid hyperthermiaon lewis lung cancer-bearing mice. Biomed Rep. 2016;50(1):59–62. doi:10.3892/br.2015.540
   Google Scholar
• Zhou S, Palmeira CM, Wallace KB. Doxorubicin-induced persistent oxidative stress to cardiac myocytes. Toxicol Lett. 2001;121(3):151–157. doi:10.1016/S0378-4274(01)00329-011369469
   PubMed Web of Science ®Google Scholar
• Srivastava G, Mehta JL. Currying the heart: curcumin and cardioprotection. J Cardiovasc Pharmacol Ther. 2009;14(1):22–27. doi:10.1177/107424840832960819153099
   PubMed Web of Science ®Google Scholar
• Namdari M, Eatemadi A. Cardioprotective effects of curcumin-loaded magnetic hydrogel nanocomposite (nanocurcumin) against doxorubicin-induced cardiac toxicity in rat cardiomyocyte cell lines. Artif Cell Nanomed B. 2017;45(4):731–739. doi:10.1080/21691401.2016.1261033
   PubMed Web of Science ®Google Scholar
• Rahman CV, Kuhn G, White LJ, et al. PLGA/PEG-hydrogel composite scaffolds with controllable mechanical properties. J Biomed Mater Res B. 2013;101B(4):648–655. doi:10.1002/jbm.b.32867
   Web of Science ®Google Scholar
• Li XY, Dou JF, Wang S, Zhang L, Zhai GX. Preparation and characteristics of curcumin loaded microemulsion based in situ thermosensitive gelling system. Pharm Biotechno. 2013;020(003):225–228.
   Google Scholar
• Chen X, Zhi F, Jia X, et al. Enhanced brain targeting of curcumin by intranasal administration of a thermosensitive poloxamer hydrogel. J Pharm Pharmacol. 2013;65(6):807–816. doi:10.1111/jphp.1204323647674
   PubMed Web of Science ®Google Scholar
• Sudhakar K, Rao KM, Subha MCS, et al. Temperature-responsive poly(-vinylcaprolactam-co-hydroxyethyl methacrylate) nanogels for controlled release studies of curcumin. Des Monomers Polym. 2015;18(8):705–713. doi:10.1080/15685551.2015.1070497
   Web of Science ®Google Scholar
• Gao M, Bao X, Lei AN, et al. Retention time of curcumin thermosensitive hydrogels for injection in solid tumor. China Pharm. 2012;23(3):206–208.
   Google Scholar
• Gao M, Xu H, Zhang C, et al. Preparation and characterization of curcumin thermosensitive hydrogels for intratumoral injection treatment. Drug Dev Ind Pharm. 2014;40(11):1557–1564. doi:10.3109/03639045.2013.83857924059282
   PubMed Web of Science ®Google Scholar
• Chen P, Zhang H, Cheng S, et al. Development of curcumin loaded nanostructured lipid carrier based thermosensitive in situ gel for dermal delivery. Colloids Surfaces A. 2016;506:356–362. doi:10.1016/j.colsurfa.2016.06.054
   Google Scholar
• Chen D, Yu H, Mu H, et al. Novel chitosan derivative for temperature and ultrasound dual-sensitive liposomal microbubble gel. Carbohydr Polym. 2013;94(1):17–23. doi:10.1016/j.carbpol.2012.12.06923544504
   PubMed Web of Science ®Google Scholar
• Cagel M, Tesan FC, Bernabeu E, et al. Polymeric mixed micelles as nanomedicines: achievements and perspectives. Eur J Pharm Biopharm. 2017;113:211–228. doi:10.1016/j.ejpb.2016.12.01928087380
   PubMed Web of Science ®Google Scholar
• Biswas S, Kumari P, Lakhani PM, et al. Recent advances in polymeric micelles for anti-cancer drug delivery. Eur J Pharm Sci. 2016;83:184–202. doi:10.1016/j.ejps.2015.12.03126747018
   PubMed Web of Science ®Google Scholar
• Yi Y, Lin G, Chen SY, et al. Polyester micelles for drug delivery and cancer theranostics: current achievements, progresses and future perspectives. Mater Sci Eng C. 2017;83(2):218–232. doi:10.1016/j.msec.2017.10.004
   PubMedGoogle Scholar
• Zhang W, Cui T, Liu L, et al. Improving anti-tumor activity of Curcumin by polymeric micelles in thermosensitive hydrogel system in colorectal peritoneal carcinomatosis model. J Biomed Nanotechnol. 2015;11(7):1173–1182. doi:10.1166/jbn.2015.207326307840
   PubMed Web of Science ®Google Scholar
• Hu YF, Darcos V, Monge S, et al. Thermo-responsive release of curcumin from micelles prepared by self-assembly of amphiphilic P(NIPAAm-co-DMAAm)-b-PLLA-b-P(NIPAAm-co-DMAAm) triblock copolymers. Int J Pharm. 2014;476(1–2):31–40. doi:10.1016/j.ijpharm.2014.09.02925260217
   PubMedGoogle Scholar